SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $311,508 | +109.4% | 30,570 | +86.4% | 0.01% | +133.3% |
| Q1 2023 | $148,775 | +48.7% | 16,403 | +17.6% | 0.00% | +50.0% |
| Q4 2022 | $100,043 | -62.4% | 13,953 | -65.8% | 0.00% | -71.4% |
| Q3 2022 | $266,000 | -35.4% | 40,751 | -52.3% | 0.01% | -36.4% |
| Q2 2022 | $412,000 | -16.3% | 85,462 | -1.4% | 0.01% | 0.0% |
| Q1 2022 | $492,000 | +13.1% | 86,635 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $435,000 | -24.5% | 86,635 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $576,000 | -24.5% | 86,635 | -30.6% | 0.02% | -36.0% |
| Q2 2021 | $763,000 | -14.7% | 124,827 | -7.2% | 0.02% | -26.5% |
| Q1 2021 | $895,000 | +12.3% | 134,516 | -10.7% | 0.03% | +13.3% |
| Q4 2020 | $797,000 | -29.7% | 150,699 | -1.0% | 0.03% | -56.5% |
| Q3 2020 | $1,134,000 | +1.2% | 152,241 | +0.0% | 0.07% | -10.4% |
| Q2 2020 | $1,120,000 | +31.1% | 152,211 | +31.9% | 0.08% | +8.5% |
| Q1 2020 | $854,000 | – | 115,388 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,561,474 | $17,166,000 | 4.25% |
| AIGH Capital Management LLC | 1,346,724 | $6,491,000 | 1.71% |
| Worth Venture Partners, LLC | 335,985 | $1,784,000 | 1.05% |
| Ikarian Capital, LLC | 884,008 | $4,261,000 | 0.78% |
| Orbimed Advisors | 4,797,148 | $23,122,000 | 0.42% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $13,014,000 | 0.23% |
| Sandy Cove Advisors, LLC | 10,592 | $51,000 | 0.05% |
| Belvedere Trading LLC | 239,219 | $1,270,000 | 0.04% |
| IPG Investment Advisors LLC | 14,300 | $69,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $637,000 | 0.02% |